Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer

Background: Despite the risk of lymph node metastasis (LNM), the indications of endoscopic submucosal dissection (ESD) has expanded to undifferentiated type (UD-type) early gastric cancer (EGC). There is debate as to whether the endoscopic resection can be used. This study was conducted to evaluate...

Full description

Bibliographic Details
Main Authors: Xiao-Qin Liang, Zhuo Wang, Hong-Tao Li, Gui Ma, Wen-Wen Yu, Hai-Cun Zhou, Hong-Bin Liu
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Asian Journal of Surgery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1015958419308826
_version_ 1818512552564359168
author Xiao-Qin Liang
Zhuo Wang
Hong-Tao Li
Gui Ma
Wen-Wen Yu
Hai-Cun Zhou
Hong-Bin Liu
author_facet Xiao-Qin Liang
Zhuo Wang
Hong-Tao Li
Gui Ma
Wen-Wen Yu
Hai-Cun Zhou
Hong-Bin Liu
author_sort Xiao-Qin Liang
collection DOAJ
description Background: Despite the risk of lymph node metastasis (LNM), the indications of endoscopic submucosal dissection (ESD) has expanded to undifferentiated type (UD-type) early gastric cancer (EGC). There is debate as to whether the endoscopic resection can be used. This study was conducted to evaluate risk factors for LNM in undifferentiated early gastric cancer, implications for the indication of the ESD so as to providing evidence for proper clinical management for UD-type EGC. Method: We retrospectively analyzed 203 patients with UD-type EGC who underwent gastrectomy for primary gastric adenocarcinoma between 2012 and 2017. We evaluated the relationship between the clinicopathological factors and the presence of LNM using univariable and multivariable logistic regression analyses. Results: A total of 203 UD-type EGC patients were enrolled, and LNM was positive in 40 cases (19.7%). Multivariable logistic regression analysis identified three independent risk factors for LNM, the tumor size (≥2.0 cm, P < 0.001), depth of invasion (P < 0.001), and lymphatic vessel involvement (LVI, P < 0.001). LNM was observed in 5.9% patients without the three predictive factors in UD-type EGC, whereas 7.7% and 37.7% of patients with one and two risk factors had LNM, respectively. In contrast, the LNM rate was up to be 66.7% in patients with three factors. Of 41 patients satisfying the expanded indication of ESD, 3 patients (7.3%) showed LNM. LNM was not found in any of 12 patients with small intramucosal lesions (<1.0 cm) without LVI. Conclusions: LNM-related risk factors were tumor larger than 2.0 cm, submucosal invasion, and the presence of LVI in UD-type EGC. ESD alone may be sufficient treatment for the intramucosal UD-type EGC that is smaller than 1.0 cm in size. When endoscopically resected specimens show unexpectedly larger tumor size, unexpected submucosal and LVI than that determined at pre-ESD endoscopic diagnosis, an additional gastrectomy with lymphadenectomy should be considered.
first_indexed 2024-12-10T23:48:27Z
format Article
id doaj.art-b90c4749f7b14ba387befd800e08d922
institution Directory Open Access Journal
issn 1015-9584
language English
last_indexed 2024-12-10T23:48:27Z
publishDate 2020-10-01
publisher Elsevier
record_format Article
series Asian Journal of Surgery
spelling doaj.art-b90c4749f7b14ba387befd800e08d9222022-12-22T01:28:51ZengElsevierAsian Journal of Surgery1015-95842020-10-014310973977Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancerXiao-Qin Liang0Zhuo Wang1Hong-Tao Li2Gui Ma3Wen-Wen Yu4Hai-Cun Zhou5Hong-Bin Liu6Second Clinical Medical College, Lanzhou University, Lanzhou, 730030, Gansu Province, China; Department of Pathology, Gansu Province People's Hospital, Lanzhou, 730000, Gansu Province, ChinaDepartment of Pathology, Gansu Province People's Hospital, Lanzhou, 730000, Gansu Province, ChinaDepartment of General Surgery, The 940th of Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou, 730050, Gansu Province, ChinaDepartment of Pathology, Gansu Provincial Cancer Hospital, Lanzhou, 730050, Gansu Province, ChinaSecond Clinical Medical College, Lanzhou University, Lanzhou, 730030, Gansu Province, ChinaSecond Clinical Medical College, Lanzhou University, Lanzhou, 730030, Gansu Province, ChinaSecond Clinical Medical College, Lanzhou University, Lanzhou, 730030, Gansu Province, China; Department of General Surgery, The 940th of Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou, 730050, Gansu Province, China; Corresponding author. Second Clinical Medical College, Lanzhou University, No. 82 Chuiying Gate, Chengguan District, Lanzhou, 730030, Gansu Province, China.Background: Despite the risk of lymph node metastasis (LNM), the indications of endoscopic submucosal dissection (ESD) has expanded to undifferentiated type (UD-type) early gastric cancer (EGC). There is debate as to whether the endoscopic resection can be used. This study was conducted to evaluate risk factors for LNM in undifferentiated early gastric cancer, implications for the indication of the ESD so as to providing evidence for proper clinical management for UD-type EGC. Method: We retrospectively analyzed 203 patients with UD-type EGC who underwent gastrectomy for primary gastric adenocarcinoma between 2012 and 2017. We evaluated the relationship between the clinicopathological factors and the presence of LNM using univariable and multivariable logistic regression analyses. Results: A total of 203 UD-type EGC patients were enrolled, and LNM was positive in 40 cases (19.7%). Multivariable logistic regression analysis identified three independent risk factors for LNM, the tumor size (≥2.0 cm, P < 0.001), depth of invasion (P < 0.001), and lymphatic vessel involvement (LVI, P < 0.001). LNM was observed in 5.9% patients without the three predictive factors in UD-type EGC, whereas 7.7% and 37.7% of patients with one and two risk factors had LNM, respectively. In contrast, the LNM rate was up to be 66.7% in patients with three factors. Of 41 patients satisfying the expanded indication of ESD, 3 patients (7.3%) showed LNM. LNM was not found in any of 12 patients with small intramucosal lesions (<1.0 cm) without LVI. Conclusions: LNM-related risk factors were tumor larger than 2.0 cm, submucosal invasion, and the presence of LVI in UD-type EGC. ESD alone may be sufficient treatment for the intramucosal UD-type EGC that is smaller than 1.0 cm in size. When endoscopically resected specimens show unexpectedly larger tumor size, unexpected submucosal and LVI than that determined at pre-ESD endoscopic diagnosis, an additional gastrectomy with lymphadenectomy should be considered.http://www.sciencedirect.com/science/article/pii/S1015958419308826Early gastric cancerEndoscopic submucosal dissectionLymph node metastasis
spellingShingle Xiao-Qin Liang
Zhuo Wang
Hong-Tao Li
Gui Ma
Wen-Wen Yu
Hai-Cun Zhou
Hong-Bin Liu
Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer
Asian Journal of Surgery
Early gastric cancer
Endoscopic submucosal dissection
Lymph node metastasis
title Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer
title_full Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer
title_fullStr Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer
title_full_unstemmed Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer
title_short Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer
title_sort indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer
topic Early gastric cancer
Endoscopic submucosal dissection
Lymph node metastasis
url http://www.sciencedirect.com/science/article/pii/S1015958419308826
work_keys_str_mv AT xiaoqinliang indicationforendoscopictreatmentbasedontheriskoflymphnodemetastasisinpatientswithundifferentiatedearlygastriccancer
AT zhuowang indicationforendoscopictreatmentbasedontheriskoflymphnodemetastasisinpatientswithundifferentiatedearlygastriccancer
AT hongtaoli indicationforendoscopictreatmentbasedontheriskoflymphnodemetastasisinpatientswithundifferentiatedearlygastriccancer
AT guima indicationforendoscopictreatmentbasedontheriskoflymphnodemetastasisinpatientswithundifferentiatedearlygastriccancer
AT wenwenyu indicationforendoscopictreatmentbasedontheriskoflymphnodemetastasisinpatientswithundifferentiatedearlygastriccancer
AT haicunzhou indicationforendoscopictreatmentbasedontheriskoflymphnodemetastasisinpatientswithundifferentiatedearlygastriccancer
AT hongbinliu indicationforendoscopictreatmentbasedontheriskoflymphnodemetastasisinpatientswithundifferentiatedearlygastriccancer